Pluton Biosciences
St. Louis, US · Founded 2017 · Delaware corporation · 28 employees on LinkedIn · 11 known investors
Find your way into Pluton Biosciences
202 people in our graph share verified history with the Pluton Biosciences team — schools, employers, funds. One of them is your warm intro.
Charles White, Ph.D.unlockedknows Barry Goldman · together at Pluton Biosciences (overlapped)
×11knows the team · via University of Utah
Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers. Its products are in development and designed to integrate with existing fertilizer and biological input programs in modern agriculture.
Founders & leadership
Pluton Biosciences was founded in 2017 by Barry Goldman.
BG
Barry GoldmaninFounder · Chief Executive Officer2021–2021Barry Goldman is co-founder of Pluton Biosciences, which develops microbial-based soil nutrient systems for agriculture. He has a background in genomic science.
EG
JS
Jerry SteinerinExecutive Chair
CW
Charlie WalchNamed on SEC filing
GS
Glendon SchusterNamed on SEC filing
Investors · 11
First In Ventures✓ verifiedMiddletown · $50K – $200K
Illumina Ventures✓ verifiedFoster City
Radicle Growth✓ verifiedSan Diego
Better Ventures✓ verifiedOakland
Fall Line Capital✓ verifiedSan Francisco
Grantham Foundation✓ verifiedBoston
RA Capital✓ verifiedBoston
The Yield Lab✓ verifiedSingapore · $48K – $12M
.png)
Better Ventures Central LlcOakland · $500K – $1.5M
iSelect FundSt. Louis · $250K – $2M
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
Reported raises · per SEC filings
Form D private placements$24.3M disclosed across 2 of 3 rounds · 2019–2023
▶$17.6MraisedJun 2023 · 12 investors · BiotechnologyRule 506(b)
▶$17.6MraisedJun 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald SteinerDirector
- Charles LinDirector
- Elizabeth GallegosExecutive Officer, Director
- Neal GuttersonDirector
- Clay MitchellDirector
- Barry GoldmanExecutive Officer, Director
- Michael GillespieDirector
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- Minimum investment
- $75K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedOct 2021 · 38 investors · BiotechnologyRule 506(b)
▶$6.7MraisedOct 2021 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles WalchExecutive Officer
- Glendon SchusterDirector
- Barry GoldmanExecutive Officer, Director
- Steven SlaterExecutive Officer, Director
- Clay MitchellDirector
- Wesley SelkeDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- Minimum investment
- $10.3K
- First sale
- Sep 2021
- Incorporated
- Corporation, Missouri, 2017
- Federal exemptions
- 06b
▶$1MofferedJan 2019 · BiotechnologyRule 506(c)
▶$1MofferedJan 2019 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Charlie WalchExecutive Officer, Director
- Barry GoldmanExecutive Officer, Director
- Glendon SchusterDirector
- Offering amount
- $1M
- Minimum investment
- $30K
- Proceeds to insiders
- $120K
- Incorporated
- Limited Liability Company, Missouri, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Pivot Bio9 shared keywordsPivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics. The company serves farmers worldwide.
Concertobio7 shared keywordsConcerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
Octant Bio5 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Anto Biosciences5 shared keywordsAnto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
Intuitive Biosciences5 shared keywordsIntuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
Pluto4 shared keywordsPluto Bio provides a cloud-based, AI-native platform for multi-omics data analysis and program management, letting scientists organize experiments, run transcriptomics, proteomics, spatial, and single-cell analyses, and generate publication-ready visualizations without coding. It serves pharma and translational science teams, academic research labs, and CROs, and spun out of Harvard's Wyss Institute.
Ditto Biosciences4 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
Companies competing with Pluton Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pluton Biosciences do?
- Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers. Its products are in development and designed to integrate with existing fertilizer and biological input programs in modern agriculture.
- Who founded Pluton Biosciences?
- Pluton Biosciences was founded by Barry Goldman in 2017.
- Who are Pluton Biosciences's investors?
- Pluton Biosciences's investors include First In Ventures, Illumina Ventures, Radicle Growth, Better Ventures, Fall Line Capital, Grantham Foundation, RA Capital, The Yield Lab and 3 more.
- How much funding has Pluton Biosciences raised?
- Pluton Biosciences has disclosed $24.3M raised across 2 of its 3 known rounds.
- Where is Pluton Biosciences headquartered?
- Pluton Biosciences is headquartered in St. Louis, US.